Cite
Martin P, Palmer G, Rodriguez E, et al. Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling. Immun Inflamm Dis. 2015;3(3):239-46doi: 10.1002/iid3.62.
Martin, P., Palmer, G., Rodriguez, E., Woldt, E., Mean, I., James, R. W., Smith, D. E., Kwak, B. R., & Gabay, C. (2015). Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling. Immunity, inflammation and disease, 3(3), 239-46. https://doi.org/10.1002/iid3.62
Martin, Praxedis, et al. "Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling." Immunity, inflammation and disease vol. 3,3 (2015): 239-46. doi: https://doi.org/10.1002/iid3.62
Martin P, Palmer G, Rodriguez E, Woldt E, Mean I, James RW, Smith DE, Kwak BR, Gabay C. Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling. Immun Inflamm Dis. 2015 Sep;3(3):239-46. doi: 10.1002/iid3.62. Epub 2015 May 10. PMID: 26417439; PMCID: PMC4578523.
Copy
Download .nbib